Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under Section 904(a)(3) of the Federal Food, Drug, and Cosmetic Act: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 3, 2012
July 28, 2020
5c927cd9-04a6-4a65-a37e-c8bae7b609fa
Related Documents
Hospital and Health System Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry
Guidance DocumentOctober 6, 2021Center for Drug Evaluation and Research
Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act
Guidance DocumentJuly 11, 2014Center for Drug Evaluation and Research
Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers: Questions and Answers Guidance for Industry
Guidance DocumentJanuary 10, 2017Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.